Combining technologies
for workflow optimization

Empower data-driven decisions providing a deeper understanding of patient health, facilitating personalized treatment plans and improved outcomes thanks to the combination of technologies that deliver a more complete picture of a patient's condition.

The Antiphospholipid Syndrome (APS) is an autoimmune disorder characterized by the presence of autoantibodies against phospholipid-binding proteins, leading to arterial and/or venous thrombosis, pregnancy morbidity, and the presence of circulating antiphospholipid (aPL) antibodies or lupus anticoagulant (LAC). This condition affects women five times more than men.

The necessity of accurate and timely diagnosis to manage APS effectively is crucial to address the complexity of this condition. 

Laboratories play a pivotal role in the diagnosis and management of APS, using a combination of different technologies to ensure accurate and reliable results.
Werfen offers a comprehensive and fully automated APS reagent menu for the Hemostasis laboratory, combining both LAC testing solutions and immunoturbidimetric assay, which are essential for the accurate diagnosis and management of APS.

The integration of HemoHub as a central information concentrator enables automated investigation of APS. This integration facilitates efficient and accurate diagnosis by providing a comprehensive overview of the patient's condition. This means having access to all relevant information in one place, reducing the risk of errors and improving patient outcomes. HemoHub streamlines the diagnostic process, ensuring that all necessary tests are performed, and results are accurately recorded.

Documents

Videos